Thalidomide to Patients With Previously Untreated Multiple Myeloma

NCT00218855 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

363

Enrollment

OTHER

Sponsor class

Conditions

Multiple Myeloma

Interventions

DRUG: thalidomide
DRUG: placebo

Sponsor

Norwegian University of Science and Technology

Collaborators

[object Object]
[object Object]